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Abstract 
Background: The mammalian sperm-associated antigen 16 gene (Spag16) uses alternative promoters to produce 
two major transcript isoforms (Spag16L and Spag16S) and encode proteins that are involved in the cilia/flagella 
formation and motility. In silico analysis of both mouse and human SPAG16L promoters reveals the existence of mul-
tiple putative SOX5 binding sites. Given that the SOX5 gene encodes a 48-kDa transcription factor (S-SOX5) and the 
presence of putative SOX5 binding sites at the SPAG16L promoter, regulation of SPAG16L expression by S-SOX5 was 
studied in the present work.
Results: S-SOX5 activated human SPAG16L promoter activity in the human bronchial epithelia cell line BEAS-2B cells. 
Mutation of S-SOX5 binding sites abolished the stimulatory effect. Overexpression of S-SOX5 resulted in a significant 
increase in the abundance of SPAG16L transcripts whereas silencing of S-SOX5 by RNAi largely reduced the SPAG16L 
expression. Chromatin immunoprecipitation assays showed that S-SOX5 directly interacts with the SPAG16L promoter.
Conclusion: S-SOX5 regulates transcription of human SPAG16L gene via directly binding to the promoter of SPAG16L. 
It has been reported that expression of sperm-associated antigen 6 (SPAG6), encoding another axonemal protein, is 
activated by S-SOX5. Therefore, S-SOX5 may regulate formation of motile cilia/flagella through globally mediating 
expression of genes encoding axonemal proteins.
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Background
The family of Sox transcription factors is defined by the 
presence of a conserved high mobility-group (HMG) 
domain that mediates DNA-binding and is highly similar 
to that of the sex-determining region (SRY) protein [1, 2]. 
Based on phylogenic analysis of HMG domain sequences 
and full-length protein sequences/functional features, 
Sox genes are classified into 10 groups from A to J [3]. 
They display distinct tissue-specific expression patterns 
and have been implicated in regulation of a wide range 
of developmental processes [1]. SOX proteins exert gene 
activation or repression by binding to a consensus DNA 
motif, with or without aid of other transcription fac-
tors [1, 4]. Available evidence indicates that a particular 
SOX protein can mediate expression of various target 
genes through recognizing different binding sites during 
the formation of many tissues [1, 5]. Selection of spe-
cific target genes by SOX proteins depends on flanking 
sequences of the consensus core, homo-/hetero-dimeri-
zation of SOX proteins at recognition sites and associa-
tion with other transcription factors [1, 6].
The SOXD group is composed of SOX5, SOX6 and 
SOX13 [1]. Human SOX5 is primarily expressed in the 
short (S-SOX5) and long form (L-SOX5) of transcripts [7, 
8]. L-SOX5 cDNA is predicted to encode a 763-amino-
acid protein that exceeds S-SOX5 by 416 residues [8]. 
S-SOX5, which lacks N-terminal domain required for 
dimerization with other SOXD proteins, is predomi-
nantly detected in testis and brain while L-SOX5 is 
expressed in multiple tissues including testis, heart, liver 
Open Access
BMC Molecular Biology
*Correspondence:  zhangling@wust.edu.cn;  
zhibing.zhang@vcuhealth.org 
†Ling Zhang and Yunhao Liu are contributed equally to this work
2 Department of Obstetrics and Gynecology, Virginia Commonwealth 
University, Richmond, VA 23298, USA
Full list of author information is available at the end of the article
Page 2 of 9Zhang et al. BMC Molecular Biol  (2017) 18:2 
and skeletal muscle [7, 8]. The difference in the pro-
tein structure and tissue distribution between the two 
forms of SOX5 implies distinct biological functions for 
these isoforms. The two SOX5 isoforms are conserved 
in mouse [9]. Mouse S-Sox5 was originally cloned from 
testis [10]. The restricted presence of mouse orthologue 
S-SOX5 proteins in round spermatids and regulation 
of testis-related gene expression by S-SOX5 suggests 
that S-SOX5 plays a specialized role in spermatogenesis 
within the testis [10–13]. Later studies demonstrated that 
mouse S-SOX5 is also expressed in the lung and brain, 
tissues bearing motile cilia [9], and it is capable of acti-
vating expression of sperm-associated antigen 6 gene 
(Spag6), whose translated product is enriched in the tis-
sues with motile cilia, particularly in the testis [9].
Mammalian sperm-associated antigen 16 (Spag16) 
is the orthologue of Chlamydomonas reinhardtii pf20 
that encodes an axonemal protein essential for flagellar 
motility. Chlamydomonas mutants carrying pf20 muta-
tion display paralyzed flagella with defects in axonemal 
central apparatus [14]. Both mouse and human SPAG16 
genes are expressed as two major transcripts of 1.4 and 
2.5  kb with different expression patterns. The human 
1.4 kb transcript was detected in multiple tissues whereas 
the human 2.5 transcript was highly expressed in testis 
[15, 16]. Mouse 2.5 kb transcript has a similar tissue dis-
tribution as the human orthologue; however, the 1.4  kb 
transcript is only present in mouse testis [17]. The trans-
lated 71 kDa (SPAG16L) and 35 kDa (SPAG16S) proteins 
have different locations and functions in male germ cells. 
SPAG16L is located in the axoneme central apparatus of 
sperms and plays a crucial role in sperm motility. Besides 
the similar localization as SPAG16L, SPAG16S is also 
present in the nucleus of post-meiotic germ cells and 
seems to be essential for viability of these cells during 
spermatogenesis [16, 18, 19].
Given that both S-SOX5 and SPAG16L are present 
in tissues containing cells with motile cilia/flagella, it is 
hypothesized that expression of SPAG16L is regulated by 
S-SOX5. In the present work, we report bioinformatic 
and biochemical characterization of the human SPAG16L 
promoter. The in silico prediction showed multiple puta-
tive binding sites for SOX5 in the SPAG16L promote 
region. The empirical evidence revealed that S-SOX5 
activates expression of SPAG16L via direct interaction 
with SOX5 binding sites at the SPAG16L promoter.
Results
S‑SOX5 stimulates human SPAG16L promoter in BEAS‑2B 
cells
We have previously used the ConSite program to predict 
transcription factors of human SPAG16L and found mul-
tiple putative SOX5-binding sites in the 2-kb proximal 
promoter region of SPAG16L [9]. To explore the influence 
of S-SOX5 on expression of SPAG16L, a transcriptional luc 
fusion was made by cloning a 2-kb DNA fragment con-
taining the SPAG16L proximal promoter into pGL3-basic 
vector. The resultant construct (SPAG16/pGL3) was co-
transfected with S-SOX5 expression plasmids (S-SOX5/
pcDNA3) into human bronchial epithelial cells BEAS-2B 
and the relative luciferase activity was measured. Endoge-
nous expression of S-SOX5 has been reported in BEAS-2B 
cells, suggesting this cell line can be used to study S-SOX5-
mediated gene regulation [9]. The basal level of SPAG16L 
expression was detected, which is about 10× higher than 
that of the control empty pGL3-basic plasmids. When co-
transfected with S-SOX5, the relative luciferase activity 
was elevated about 100-folds (Fig. 1). These results indicate 
that S-SOX5 stimulates transcription of human SPAG16L.
Levels of SPAG16L mRNA are elevated by exogenous 
S‑SOX5
The effect of S-SOX5 on the expression level of SPAG16L 
mRNA in BEAS-2B cells was examined. To this end, 
BEAS-2B cells stably expressing S-SOX5 (S-SOX5/
pcDNA3) or infected with S-SOX5 adenovirus (Ad/S-
SOX5) were generated, and expression of S-SOX5 protein 
in these cells was confirmed by Western blot analysis. 
Even though, S-SOX5 was undetected in the controls, 
the S-SOX5 protein (48 kDa) was produced in both cell 
lines and clearly increased when infected with S-SOX5 
adenovirus (Fig. 2a). To measure the relative abundance 
of SPAG16L mRNA in the same cells, real-time PCR was 
performed. As expected, the relative level of SPAG16L 
mRNA in both cell types was significantly higher than 
that in the control (Fig. 2b). The results show that exog-
enous S-SOX5 is able to increase SPAG16L mRNA levels.
Knockdown of S‑SOX5 in BEAS‑2B cells reduces expression 
of SPAG16L
To further investigate the regulatory role of S-SOX5 on 
SPAG16L expression, two human SOX5 RNAi constructs 
that respectively target portion 225-246 and 1109-1130 
of the SOX5 transcript were used [9]. The BEAS-2B 
cells were co-transfected with these constructs or SOX5 
expression plasmids (S-SOX5/pcDNA3). The efficiency 
of the SOX5 RNAi plasmids was examined by Western 
blot analysis. Both RNAi constructs were able to decrease 
S-SOX5 protein levels, but the construct targeting por-
tion 1109-1130 of the SOX5 transcript led to a remark-
able reduction of S-SOX5 (Fig.  3a, b). Moreover, the 
abundance of SPAG16L mRNA in the BEAS-2B cells 
was measured by real-time PCR. It was decreased corre-
spondingly with two different RNAi constructs (Fig. 3c). 
These data suggest that expression of SPAG16L depends 
on the activity of S-SOX5 protein.
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S‑SOX5 binds to the human SPAG16L promoter
To study the molecular interaction between S-SOX5 and 
the SPAG16L promoter, BEAS-2B cells were infected 
with S-SOX5 adenovirus (AdS-SOX5) and ChIP assay 
was conducted with an antibody specifically against 
S-SOX5 or rabbit IgG. Two primer sets flanking puta-
tive SOX5 binding sites were designed; as a control, 
another primer set located about 3  kb upstream of the 
transcriptional start site without flanking any SOX5 
binding site was also designed (Fig.  4A). Compared to 
using the rabbit IgG, more PCR products were amplified 
by two PCR primer sets flanking putative SOX5 binding 
sites when ChIP was performed using the SOX5 antibody 
(Fig. 4B, b, c). However, the control primer set was unable 
to amplify more specific DNA fragments (Fig. 4B, a). The 
result was consistent with the statistical analysis of the 
Fig. 1 Effect of S-SOX5 on the human SPAG16L promoter activity. 2-kb human SPAG16L promoter construct was transfected to BEAS-2B cells. The 
cells were also co-transfected with S-SOX5/pcDNA3 or empty pcDNA3 plasmid. The promoter activity was measured by dual luciferase assays after 
48 h transfection. Values indicate mean ± S.E. (error bars) of the relative luciferase activity (n = 3). *p < 0.05 (Student’s t test) compared to the control
Fig. 2 Exogenous S-SOX5 up-regulates SPAG16L mRNA expression in BEAS-2B cells. a Western blot analysis of S-SOX5 protein levels in BESA-2B cells 
stably expressing S-SOX5 (left) or infected with AdS-SOX5 (right) detected with the Pico system. b Analysis of SPAG16L mRNA expression by real-time 
PCR. GAPDH was also amplified simultaneously to normalize the results. Values indicate mean ± S.E. (error bars) of the relative mRNA level (n = 3). 
*p < 0.05 (Student’s t test) compared to the controls
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relative abundance of the PCR products (Fig. 4C). These 
results suggest that S-SOX5 is capable of binding to the 
promoter of SPAG16L.
Mutation of SOX5 binding sites abolishes activation of the 
SPAG16L promoter in BEAS‑2B cells
To study if S-SOX5 activates SPAG16L transcription 
via interacting with the SOX5 binding sites, a 300-bp 
SPAG16L promoter construct encompassing two puta-
tive SOX5 binding sites was generated. The resultant 
transcriptional fusion construct was transfected into 
BEAS-2B cells and relative luciferase activity was ana-
lyzed. The SPAG16L promoter showed basal level activ-
ity which is about 10× higher than that of the control 
(pGL3 only). As expected, co-transfection of S-SOX5 
largely stimulated the SPAG16L promoter activity when 
both putative SOX5 binding sites (P-I & P-II) were pre-
sent (Fig. 5). Mutation in the P-II site had little effect on 
the elevation of SPAG16L promoter activity, suggesting 
that the P-II site is not required for S-SOX5-mediated 
activation of SPAG16L. Interestingly, mutations in either 
the P-I site or both sites (P-I & P-II) led to higher base-
line promoter activities; however, the promoter activities 
were not increased in the presence of S-SOX5 (Fig.  5). 
The results suggest that the P-I site probably contributes 
to the repression of SPAG16L by unknown factor(s) in 
the absence of S-SOX5 and is also essential for activation 
of SPAG16L by S-SOX5.
Fig. 3 Knockdown of S-SOX5 in BEAS-2B cells by RNAi results in decrease of SPAG16L mRNA. a Western blot analysis of S-SOX5 proteins in BEAS-2B 
cells stably expressing two RNAi constructs. b After RNAi treatment, the levels of S-SOX5 in BEAS-2B cells were estimated by analysing intensity of 
protein bands using ImageJ software. c Analysis of SPAG16L mRNA expression by real-time PCR in BEAS-2B cells transfected with two SOX5 RNAi 
constructs. Silencing of S-SOX5 by RNAi reduced expression of SPAG16L. Values indicate mean ± S.E. (error bars) of the relative mRNA level (n = 3). 
*p < 0.05 (Student’s t test) compared to the control
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Discussion
Cilia are evolutionarily conserved, filamentous cellular 
structures that are present on the cell surface and have 
been implicated in the sensing of environmental signals 
and cellular motility [20]. Based on the axonemal archi-
tectures, cilia can be classified into two major forms: 
“9 + 0” and “9 + 2” axonemal arrangements [20]. Primary 
cilia contain a “9 + 0” axoneme and usually non-motile, 
and detect mechanical and chemical signals from the sur-
rounding environment. Dysfunction of primary cilia can 
lead to various human diseases including primary ciliary 
dyskinesia, polycystic kidney disease and retinal degen-
eration [21]. Motile cilia have a “9 + 2” axoneme that is 
composed of nine doublet microtubules and a central 
pair of microtubules. The associated structures of the 
“9 + 2” axoneme such as radial spokes and dynein arms 
are crucial for mediation of cilia motility [20]. Motile 
cilia are widely present in mammalian tissues including 
trachea, brain, spinal canal and sperm. Defects in motile 
cilia have been linked to diverse symptoms including 
hydrocephalus, sinusitis and bronchiectasis, situs inver-
sus and male infertility [22].
Fine-tuned regulatory mechanisms mediate expres-
sion of stage-specific genes for the formation of dis-
tinct types of cilia during ciliogenesis. The sophisticated 
genetic program of ciliogenesis is modulated prob-
ably through the precise presence and maintenance of 
essential proteins in a time- and tissue-dependent man-
ner [20, 23]. Empirical evidence shows that expression 
of ciliary genes is transcriptionally regulated and some 
transcriptional factors involved in ciliogenesis have 
been identified. These transcription factors include: 
HNF1β (hepatocyte nuclear factor 1β) [24], FKH-2 
(forkhead 2) [25], RFX family of transcription factors 
[26], and FOXJ1 transcription factors [27]. Among 
them, RFX and FOXJ1 are two major transcriptional 
factors that control ciliogenesis. RFX proteins func-
tion as transcriptional regulators that interact with the 
X-box motif at MHC class II gene promoters [26, 28]. 
Functional analyses of RFX regulators indicate that 
they are required for modulating expression of key 
genes involved in different stages of ciliogenesis, includ-
ing formation of ciliated sensory neurons, basal body 
migration and membrane docking, intraflagellar trans-
port and ciliary motility [29–32].
FOXJ1 belongs to the forkhead/winged-helix family of 
transcriptional factors [23]. Loss-of-function analyses of 
Foxj1 demonstrate the requirement of this gene for bio-
synthesis of motile cilia in mouse tissues [33, 34]. A num-
ber of target genes of FOXJ1 that are involved in ciliary 
motility have been identified in model organisms such 
as zebrafish and Xenopus. This suggests that FOXJ1 is a 
master transcriptional factor of motile ciliogenesis [35, 
36].
Fig. 4 S-SOX5 associates with the human SPAG16L promoter as revealed by ChIP assay. A Schematic representation of the human SPAG16L proximal 
promoter and the regions (a–c) amplified by ChIP primers used in this study. Arrows show the location of the primers. B Representative ChIP assay 
results with BEAS-2B cells infected by AdS-SOX5 using a control rabbit IgG or an antibody specifically against SOX5. a with a primer set not flanking 
any potential SOX5 binding sites; b and c, with primer sets flanking potential SOX5 binding sites. C qPCR quantification of ChIP products. DNA 
recovered from ChIP was used as a template for real-time PCR analysis. Data shown are mean ± S.E. (error bars) of three independent replicates. 
*p < 0.05 (Student’s t test) compared to the normal rabbit IgG pulldown group
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Our earlier studies demonstrated that S-SOX5, 
together with FOXJ1, regulates expression of an axone-
mal gene, Spag6 [9]. To explore if S-SOX5 also regulates 
other genes that are essential for motile cilia structure 
and/or function, and functions as a general transcrip-
tion factor to control motile cilia/function, we decided 
to investigate if S-SOX5 regulates another axonemal 
central apparatus gene, SPAG16L, because the SPAG16L 
proximal promoter region also contains multiple puta-
tive SOX5 binding sites. Our findings demonstrated that 
S-SOX5 does regulate SPAG16L transcription through 
binding to the SOX5 binding sites. However, it should 
be aware that not all the putative SOX5 binding sites 
predicted by bioinformatic analysis are functional. One 
of the two putative SOX5 binding sites analysed in this 
study is not bound by S-SOX5. Thus, experiments must 
be conducted to verify if these putative binding sites are 
functional. Overall, this study presents another example 
that S-SOX5 regulates another gene essential for motile 
cilia function, and supports the notion that S-SOX5 is 
a general transcription factor to control formation and 
function of motile cilia.
Sperm flagella are special motile cilia. During sper-
miogenesis, germ cells undergo dramatic morphologi-
cal changes as they develop into functional sperm. These 
changes include formation of flagella. Sperm flagella 
contain a “9  +  2” axoneme. Besides this core axoneme 
structure, other affiliated structures, including the fibrous 
sheath and outer dense fibers, are also assembled into 
the sperm flagella [37]. S-SOX5 was originally cloned 
from mouse testis [10] and it is able to activate tran-
scription of a group of testis-related gene such as IκBβ, 
ZNF230 and Catsper1 [12, 13, 38] Given that S-SOX5 is 
only expressed in tissues with motile cilia, particularly in 
the post-meiotic round spermatids [11], we hypothesize 
that this transcription factor regulates a suite of genes for 
motile cilia formation/function, particularly for sperm 
flagella formation/function. Recent GWAS studies sug-
gest that the SOX5 locus is associated with male infertil-
ity [39], and the high expression level of S-SOX5 in the 
testis implies that S-SOX5 plays an important role in 
regulating expression of the genes that are essential for 
sperm function and male fertility.
The in  vivo function of S-SOX5 is still not known. 
However, the unique exon not present in L-SOX5 allows 
us to make mutant mice with disruption of S-SOX5 only. 
Using this model, we will be able to study the function 
of S-SOX5 in vivo, and probably identify the target genes 
regulated by S-SOX5 globally.
Conclusions
This study demonstrates the molecular mechanism 
underlying the regulation of human SPAG16L by 
S-SOX5. S-SOX5 activates transcription of SPAG16L 
Fig. 5 Functional analyses of S-SOX5 binding sites in the human SPAG16L promoter. Left maps of the wild-type human SPAG16L promoter construct 
containing two putative SOX5 binding sites (P-I & P-II) and the constructs with mutations of the potential SOX5 binding sites. Right, effect of S-SOX5 
on the function of the wild-type and mutated SPAG16L promoter. BEAS-2B cells were co-transfected with SPAG16L promoter constructs and either 
pcDNA3 control or S-SOX5/pcDNA3. Relative luciferase activity, normalized to pGL3 control plasmids co-transfected with pcDNA3 vectors. Values 
are mean ± S.E. (error bars) of the relative luciferase activity (n = 3). Bars labeled with different letters are significantly different (p < 0.05; two-way 
ANOVA with Tukey’s HSD test)
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through specifically interacting with SOX5 binding sites 
at the SPAG16L promoter. The data suggest that S-SOX5 
plays a regulatory role in the formation of cilia/flagella.
Methods
Luciferase reporter constructs
The SPAG16L promoter luciferase reporter fusion was 
constructed by cloning a 2 kb human SPAG16L proximal 
promoter region including the transcriptional start site 
and multiple putative SOX5 binding sites into the pGL3-
basic vector (Cat.E1751, Promega). Similarly, another 
luciferase reporter fusion was made by cloning a shorter 
region of SPAG16L proximal promoter into the pGL3-
basic vector. This transcriptional luc fusion construct 
contained the transcriptional start site of SPAG16L and 
adjacent two putative SOX5 binding sites. The primers 
for construction of the transcriptional luc fusions were 
listed in Table 1.
Expression constructs or adenovirus expressing S‑SOX5 
and SOX5 RNAi constructs
S-SOX5 expression plasmids, the adenovirus expressing 
S-SOX5, and the RNAi constructs targeting SOX5 tran-
scripts were generated previously in the laboratory [9]. 
Oligonucleotides used for generation of these constructs 
are listed in Table 1.
Site‑directed mutagenesis of SOX5 binding sites in the 
SPAG16L promoter
Two SOX5 binding sites in the SPAG16L promoter 
construct were mutated using a QuikChange II XL 
Site-Directed Mutagenesis Kit (Agilent Technologies) 
following the manufacturer’s instructions. Mutations at 
the SPAG16L promoter were verified by DNA sequenc-
ing. The mutagenic primers for construction of mutated 
SOX5 binding sites are shown in Table 1.
Western blot analysis
Equal amount of proteins (50  µg/lane) were heated to 
95 °C in sample buffer for 10 min, resolved in 10% SDS–
polyacrylamide gels and then electro-transferred to 
polyvinylidene difluoride membranes (Millipore). After 
blocking in TBS-T buffer (Tris-buffered saline solution 
containing 5% non-fat dry milk and 0.05% Tween 20) 
for 1 h, the membranes were incubated with antibodies 
against SOX5 (Aviva Systems Biology, Santa Cruz, CA) 
or rabbit β-actin (Cell Signaling Technology, Danvers, 
MA) overnight at 4 °C. After being washed in TBS-T, the 
membranes were incubated with an anti-rabbit immuno-
globulin conjugated with horseradish peroxidase (1:2000 
dilution) at room temperature for 1  h. SOX5 or β-actin 
proteins were detected with SuperSignal West Pico 
Chemiluminescent Substrate (Pierce).
Table 1 Oligonucleotides used in this study
Primer name Sequence (5′–3′) Application
SPAG16L-promoterF1 GGTACCGGTCAAAGCGAAAGAAAACC Forward primer for transcription fusion to luc
SPAG16L-promoterR2 CTCGAGGAACAGCGAAGACGCTACCC Reverse primer for transcription fusion to luc
Human S-SOX5 forward GTGCCATAGGAGCTGTGCATG S-SOX5 expression
Human S-SOX5 reverse GTTGGTCCTTCATTTGCCGAGC
SOX5 RNAi (225) sense AAAAATGATGCTGTCACCAAGGCAA SOX5 RNAi construction
SOX5 RNAi (225) anti-sense AAAGTTGCCTTGGTGACAGCATCAT
SOX5 RNAi (1109) sense AAAAGATTATGGGAGTGACAGTGAA SOX5 RNAi construction
SOX5 RNAi (1109) anti-sense AAAGTTCACTGTCACTCCCATAATC
SPAG16L RT-PCRF TTCAGACTGCTGCTTCCATC Real-time PCR analysis of SPAG16L
SPAG16L RT-PCRR TCGCCTGTACATAGATCCCA
GAPDH RT-PCRF GGAGGTGAAGGTCGGAGTC Real-time PCR analysis of GAPDH
GAPDH RT-PCRR GAAGATG GTGATGGGATTTC
SPAG16L mutation 1F TGCAATGCAAGCCAACCACCTACTGTATCTTGTCC Mutation of SOX5 binding site (P-I site) at SPAG16L promoter
SPAG16L mutation 1R GGACAAGATACAGTAGGTGGTTGGCTTGCATTGCA
SPAG16L mutation 2F GTTAACTAGGCAACACTACCGCCACGGTAACTGGG Mutation of SOX5 binding site (P-II site) at SPAG16L promoter
SPAG16L mutation 2R CCCAGTTACCGTGGCGGTAGTGTTGCCTAGTTAAC
SPAG16L ChIP-aF CTTGGGTGACTTCCAATTTTG ChIP assays for SPAG16L site a
SPAG16L ChIP-aR GTATCATTAACTACACTCCTC
SPAG16L ChIP-bF CCTACTTGAGGAGGAGAGTGGGA ChIP assays for SPAG16L site b
SPAG16L ChIP-bR TATCGCGTATGTATCAGAAGC
SPAG16L ChIP-cF GGAAGATCCTCTCAGCAATAAGAC ChIP assays for SPAG16L site c
SPAG16L ChIP-cR GAAGAACTATGGTGTTCAGC
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Chromatin immunoprecipitation (ChIP)
ChIP assays were conducted using a ChIP assay kit (Mil-
lipore) according to the manufacturer’s instructions. 
Briefly, BEAS-2B cells were (CRL-9609) purchased from 
the American Type Culture Collection and infected with 
AdS-SOX5 for 48  h. After infection, the protein-DNA 
complexes from the cells were cross-linked by addition of 
1% formaldehyde. The cells were suspended in SDS lysis 
buffer and were sonicated to shear DNA to 200–1000 bp 
fragments. Samples were precleared with protein A aga-
rose/salmon sperm DNA (50% slurry) and were immuno-
precipitated with antibodies against SOX5 or IgG. After 
washing the immunocomplexes with appropriate buffers, 
DNA was recovered by reverse cross-linking and puri-
fied by phenol/chloroform extraction followed by ethanol 
precipitation. The DNA fragments were used as a tem-
plate for PCR reaction with primer sets (Table 1) flanking 
the SOX5 binding sites.
Transient transfection and luciferase assays
Human bronchial epithelial BEAS-2B cells were cul-
tured in BEBM and were plated 24 h before transfection. 
The cells were transfected with plasmids containing the 
wild-type or mutated SPAG16 promoter using FuGENE6 
transfection reagent (Roche). Co-transfection was per-
formed with either empty vectors or S-SOX5 expres-
sion vectors (S-SOX5/pcDNA3). The cells were cultured 
for 48  h and the promoter activity was measured by 
the Dual-Luciferase Reporter Assay System (Promega). 
Luciferase activity was normalized to Renilla luciferase 
activity (control vector).
Real‑time PCR
Total RNA was extracted from BEAS-2B cells infected 
with indicated plasmids using TRIzol Reagent (Invitro-
gen) and was reversed transcribed to cDNA. The cDNA 
was used for PCR amplification of SPAG16L, SOX5 
and GAPDH with primers listed in Table  1. Real-time 
PCR was performed using 2×  SYBR Green master mix 
(Bio-Rad).
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